Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M606Revenue $M1.2Net Margin (%)-3,005.4Altman Z-Score1.4
Enterprise Value $M460EPS $-0.2Operating Margin %-3,045.8Piotroski F-Score4
P/E(ttm)--Beneish M-Score-5.6Pre-tax Margin (%)-3,005.4Higher ROA y-yY
Price/Book4.810-y EBITDA Growth Rate %-11.6Quick Ratio3.6Cash flow > EarningsY
Price/Sales4955-y EBITDA Growth Rate %-25.8Current Ratio3.6Lower Leverage y-yY
Price/Free Cash Flow38.4y-y EBITDA Growth Rate %--ROA % (ttm)-23.2Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)-26.5Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M158ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with GERN

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
Current Price Change from Average Comment Current Shares
GERNFirst Eagle Investment 2015-03-31 Reduce$2.81 - $4.34
$ 3.8413%Reduce 35.43%728,866
GERNFirst Eagle Investment 2014-12-31 Reduce-0.01%$1.85 - $3.84
$ 3.8438%Reduce 48.64%1,128,866
GERNFirst Eagle Investment 2014-09-30 Reduce-0.01%$2.12 - $3.014
$ 3.8456%Reduce 38.05%2,198,124
GERNFirst Eagle Investment 2014-03-31 Add0.01%$1.6 - $5.4
$ 3.84-5%Add 46.43%3,054,252
GERNFirst Eagle Investment 2013-03-31 Add$1.01 - $1.64
$ 3.84178%Add 36.91%2,410,934
GERNGeorge Soros 2011-03-31 Sold Out $4.44 - $5.07
$ 3.84-18%Sold Out0
GERNFirst Eagle Investment 2010-12-31 Add0.03%$4.46 - $6.02
$ 3.84-27%Add 74.80%2,570,500
GERNGeorge Soros 2010-12-31 Buy $4.46 - $6.02
$ 3.84-27%New holding26,500
GERNFirst Eagle Investment 2010-06-30 Add0.02%$4.67 - $5.81
$ 3.84-25%Add 77.56%1,420,500
GERNFirst Eagle Investment 2010-03-31 Add0.03%$4.97 - $6.21
$ 3.84-31%Add 204.80%800,000
GERNFirst Eagle Investment 2009-12-31 Add0.02%$4.91 - $6.69
$ 3.84-31%Add 556.18%262,471
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GERN is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!

GERN: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Hofstaetter ThomasDirector 2015-03-18Sell70,000$4.1-4.15view
Bloom Olivia KyusukEVP, CFO 2014-05-29Sell3,379$2.187.14view
BEHRS MELISSA KELLYEVP Portfolio & Alliance Mgmt 2014-05-29Sell4,826$2.187.14view
BRADBURY DANIELDirector 2014-05-09Buy142,776$1.75124.57view
BEHRS MELISSA KELLYEVP Portfolio & Alliance Mgmt 2014-04-01Sell12,310$2.1384.51view
Bloom Olivia KyusukEVP, CFO 2014-04-01Sell7,435$2.1384.51view
SCARLETT JOHN APresident and CEO 2013-04-01Buy50,000$1.03281.55view
BEHRS MELISSA KELLYSVP Alliance and Prog Mgmt 2013-01-17Sell28,292$1.65138.18view
Kelsey Stephen MichaelEVP, R&D Head, CMO 2012-05-30Sell9,300$1.37186.86view
EARP DAVIDSVP, Corp Transactions 2012-05-30Sell27,155$1.37186.86view

Press Releases about GERN :

    Quarterly/Annual Reports about GERN:

    News about GERN:

    Articles On GuruFocus.com
    Weekly CEO Buys Highlight: IBTX, INSM, GERN, INO, EQU Apr 07 2013 
    Geron Corp. Reports Operating Results (10-Q) Oct 29 2010 
    Geron: Buyer Beware Oct 13 2010 
    Geron Corp. (GERN) President and CEO Thomas Okarma sells 18,874 Shares Jun 03 2010 
    Geron Corp. (GERN) EVP and CFO David Greenwood sells 14,746 Shares Jun 03 2010 
    Geron Corporation Reports 2009 Second Quarter Financial Results and Events Jul 30 2009 
    Geron Corp (GERN): Stock of the Day Mar 10 2009 
    Banking 60% on the Day the World Changed: FDA Approves Geron to Test Embryonic Stem Cells on Humans Jan 24 2009 
    The Next Boom Emerges Nov 23 2008 

    More From Other Websites
    Why Geron (GERN) Might Be a Diamond in the Rough - Tale of the Tape May 26 2015
    GERON CORP Files SEC form 8-K, Submission of Matters to a Vote of Security Holders May 22 2015
    Anne-Malorie Géron appointed as VP EU Affairs in Fortum's Corporate Relations May 21 2015
    GERON CORP Financials May 15 2015
    The Shuman Law Firm Investigates Geron Corp. May 11 2015
    10-Q for Geron Corp. May 09 2015
    GERON CORP Files SEC form 10-Q, Quarterly Report May 07 2015
    10-K for Geron Corp. May 06 2015
    Geron Q1 Loss In Line with Estimates, Restructuring on Track - Analyst Blog May 01 2015
    Geron reports 1Q loss Apr 30 2015
    Geron reports 1Q loss Apr 30 2015
    Geron Corporation Reports First Quarter 2015 Financial Results and Recent Events Apr 30 2015
    GERON CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Apr 30 2015
    4:45 pm Geron reports EPS in-line, beats on revs Apr 30 2015
    Geron Corporation Reports First Quarter 2015 Financial Results and Recent Events Apr 30 2015
    Harwood Feffer LLP Announces Investigation of Geron Corporation Apr 29 2015
    Geron Stock Alert: Schubert Firm Investigates Company's Top Executives Apr 28 2015
    Geron to Present at the Bank of America Merrill Lynch Healthcare Conference Apr 27 2015
    Geron to Present at the Bank of America Merrill Lynch Healthcare Conference Apr 27 2015
    The Zacks Analyst Blog Highlights: Gilead Sciences, Biogen, Geron, Johnson & Johnson and Anthera... Apr 22 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)